Upload
others
View
14
Download
0
Embed Size (px)
Citation preview
SUPPORTING YOUR STRATEGIC AND TACTICAL PLANNING NEEDS
IVD Gateway - the definitive source for In-Vitro Diagnostics (IVD) data for each of the major IVD segments across 36 countries and territories, delivering precise and up-to-date data, forecasts and insights to shape your business strategies and support your tactical decisions.
The Market
Credible & Up-To-Date
Deep dive into global trends and local market and customer data for all major IVD segments in APAC, EU, LATAM and ME
Data
Granular & Transparent
Annual market tracking and lab monitoring aligned with strategic and tactical sales planning exercises, with updated data available every Q1
Reporting
Accurate & Actionable
Scientific market modelling techniques enhances the accuracy and predictive effectiveness of our market forecasts and analysis
IVD Gateway supports your strategic and tactical business planning and provides answers on the what, where and how to gain market share
40+60+I 5+10+15+70+IMDx test volumex mil test in 201x
Assay type volumex mil test in 201x
WHATSizing by assay in volume
and value terms
WHEREBreakdown by
customer segment
Provides test volumes of each segment at a country level and convert volume to dollar value share by ex-manufacturer price
Determine each IVD test segment’s demand by customer segment, classified by lab throughput size and prioritise key segments to target
HOWVisibility at individual lab level
for sales effectiveness
Provides individual lab profiles with test volume by assay, installed base of analyser brands, age of instrument, replacement likelihood and future plans
www.eiu.com/ivd-gatewayEIU Healthcare | IVD Gateway
OUR SOLUTIONS
EIU Healthcare | IVD Gateway
Size and Share Plus for growth strategy planningMarket data and insights with size, share and growth estimates and forecasts for markets and competitors in all major IVD segments globally.
Granular coverage of 94 IVD sub-segments in centralised, molecular, point-of-care, tissue diagnostics and next-generation sequencing.
LabPRO Plus for tactical decision-makingWe profile ~ 3500 centralised diagnostics labs and ~1700 molecular diagnostics labs across hospitals and commercial settings.
Market SizeSize of IVD market: • In value terms, ex-manufacturer price• At country level
Further segmented by: • IVD segments and sub-segments
Tracked annually: • Latest data available annually in Q1
Competitive ShareIVD players’ market share by: • IVD segments and sub-segments• Country and region
Breakdown of share by: • International vs. regional vs. domestic
players
Track performance of players over time:• Market share gains / losses• New entry/ exit by segment and sub-
segments
Growth Projection• Historical YoY (compare to prior year)• 5-year CAGR forecasts
Drivers of / Barriers to Growth• Regulatory, reimbursement • Healthcare spending and reforms• Epidemiology and treatment trends• Technology adoption trends
We profile ~ 3500 centralised diagnostics labs and ~1700 molecular diagnostics labs across hospitals and commercial settings.
Facility details • Location: Country, city, state/ province, street, zip code
• Facility type: Hospital, commercial lab
• Facility size and classification: bed size; part of group
• Contact details (main line)
Testing profile/details
• Total annual test volume
• Breakdown of test volume by test segment
• Test volume, instrument and reagent (for MDx assays)
• Outsourced vs. in-house testing (%)
• YoY growth rates of test volume
Brands usage • Total installed base by segment
• Brands and models of analysers
• Primary and secondary
• Purchased vs rented
• LIS & automation
Future plans • Addition of new assays
• Increase throughput• Replacement vs new
tests
2
COMPREHENSIVE COVERAGE
36 countries & territories
GermanyFranceItalySpainUK
AustriaBelgiumCzech RepublicNetherlandsSwitzerland
Europe
Saudi ArabiaTurkeyUnited Arab Emirates
Middle East
BrazilMexicoColumbiaArgentinaPeru
ChileEcuador
Latin America
IndiaPakistan
South Asia
AustraliaNew Zealand
Australasia
ChinaJapanSouth KoreaTaiwanHong Kong
North Asia
IndonesiaMalaysiaMyanmarPhilippinesSingaporeThailandVietnam
Southeast Asia
3
5 primary IVD test groups 33 test segments 94 sub-segments
Molecular Diagnostics(MDx)• MDx instruments
• Blood screening (NAT)
• HPV
• Bacteriology
• Microbiology
• Virology
• Gastrointestinal
• Panels (>2 targets)
• Genetics, Oncology & Coagulation (PCR)
Point-of-Care (POC) Testing
• Cardiac
• Bloodgas & electrolytes
• Urinalysis
• Hospital glucose (connected)
• Hospital glucose (non-connected)
• Chemistry + HbA1c
• Patient monitoring /Coagulation
• Infectious diseases
• Molecular
Tissue Diagnostics(TDx)• Pre-analytical
• Primary staining
• H&E
• Special stains
• Advanced staining
• Instruments
• IHC reagents
• ISH reagents
• Workflow solutions
• Digital pathology
Next GenerationSequencing (NGS)• NGS instruments
• Sample preparation
• Testing
• NIPT
• Oncology
• Infectious diseases
Centralised Diagnostics (CEDx)
• Clinical chemistry
• Immunoassays
• Haematology
• Coagulation
• Urinalysis
• Flow cytometry
• Blood grouping & typing
• Microbiology
• IT solutions & workflow automation
www.eiu.com/ivd-gateway
4
TRUSTED WORLDWIDE
AmericasThe Economist Intelligence Unit 750 Third Ave, 5th Floor New York, NY 10017 USA
+1 (212) 554 0632
ChinaClearstate, an EIU Healthcare business 19/F Ruijin Building 205 South Mao Ming Rd Shanghai 200020
+86 21 6473 7128
Europe, Middle East & AfricaThe Economist Intelligence Unit 20 Cabot Square London E14 4QW United Kingdom
+44 (0) 20 7576 8180
Europedii, an EIU Healthcare business Schwägrichenstr. 904107 Leipzig Germany
+49 (0) 341 333 95 100
Asia-PacificClearstate, an EIU Healthcare business 21 Biopolis Road #06 - 02 Nucleos Singapore 138567
+65 715 9200
Size and Share Plus and LabPRO Plus are Economist Intelligence Unit (Healthcare) products.
With over a decade of expertise in this area and continuous acquisition of leading businesses in this field, we are confident that IVD Gateway is the most reliable and comprehensive source of IVD market data available.
Request a demo